1 Min Read
Feb 21 (Reuters) - Nippon Kayaku Co Ltd
* Says it initiated phase II clinical trials on NK105 for treatment of breast cancer
Source text in Japanese:goo.gl/nKdFZC
Further company coverage: (Beijing Headline News)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.